Dysregulated NF-κb pathway in peripheral mononuclear cells of alzheimer's disease patients

Current Alzheimer Research

Volumn 9, Issue 1, 2012, Pages 128-137

  Ascolani, Arianna ^a   Balestrieri, Emanuela ^a   Minutolo, Antonella ^a   Mosti, Serena ^b   Spalletta, Gianfranco ^c   Bramanti, Placido ^c   Mastino, Antonio ^c,d   Caltagirone, Carlo ^a,b   Macchi, Beatrice ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Alzheimer's disease; Inflammation; Mmse; Nf b; Pbmcs; Superarray

Indexed keywords

ALPHA CRYSTALLIN; APOPTOSIS REGULATORY PROTEIN; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CELL CYCLE PROTEIN; CYCLIN A2; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME P450; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 3; MINICHROMOSOME MAINTENANCE PROTEIN 4; MINICHROMOSOME MAINTENANCE PROTEIN 5; PROTEIN BCL 2; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

AGED; ALZHEIMER DISEASE; APOPTOSIS; CASE-CONTROL STUDIES; CELL CYCLE; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC;

EID: 84856452782     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512799015091     Document Type: Article

References (28)

1. Britschgi M, Wyss-Coray T. Systemic and acquired immune responses in Alzheimer's disease. Int Rev Neurobiol. 82: 205-33 (2007).
2. Zotova E, Nicoll JAR, Kalaria R, Holmes C, Boche D. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimer Res Ther 2: 1-9 (2010).
3. Blalock EM., Chen KC, Stromberg AJ, Norris CM, Kadish I, Kraner SD, et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation. Ageing Res Rev. 4: 481-512 (2005).
4. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res. 70: 462-73 (2002).
5. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20: 683-95 (2001).
6. Blalock EM, Geddes JW, Che KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A. 101: 2173-8 (2004).
7. Weeraratna AT, Kalehua A, Deleon I, Bertak D, Maher G, Wade MS, et al. Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res. 313: 450-61 (2007).
8. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature rev. Immunol. 6: 131-44 (2010).
9. Maes OC, Xu, S, Yu, B, Chertkow HM, Wang, E, Schipper HM. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging. 28: 1795-809 (2007).
10. Kálmán J, Kitajka K, Pákáski M, Zvara A, Juhász A, Vincze G, et al. Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr Genet. 15: 1-6 (2005).
11. Grunblatt E, Zehetmayer S, Ringel TM, Bauer P, Rieder P, Jacob CP. Gene expression as peripheral biomarker for sporadic Alzheimer's disease. J. Alzheimers Dis. 16: 627-34 (2009).
12. Tacconi S, Perri R, Balestrieri E, Grelli S, Bernardini S, Annichiarico R, et al. Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease. Exp Neurol. 190: 254-62 (2004).
13. Janssens S, Tschopp J. Signals from within: the DNA-damageinduced NF-kappaB response. Cell Death Differ. 13: 773-84 (2006).
14. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73: 768-774 (2009).
15. Speciale L, Calabrese E, Saresella M, Tinelli C, Mariani C, Sanvito L, et al. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging. 28: 1163-69 (2007).
16. Bonotis K, Krikki E, Holeva V, Aggouridaki C, Costa V, Baloyannis SX. Systemic immune aberrations in Alzheimer's disease patients. J Neuroimmunol. 193: 183-87 (2007).
17. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett. 114: 46-51 (2007).
18. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 13: 1359-62 (2007)
19. Castellani RJ, Lee H, Zhu X, Perry G, Smith MA. Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol. 67: 523-31 (2008).
20. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA., Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A.94: 2642-47 (1997)
21. Huang Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain. Neurosci Lett. 373: 115-18 (2005).
22. Grilli M, Ribola M, Alberici A, Valerio A, Memo M, Spano P. Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem. 270: 26774-7 (1995).
23. Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG., Perez-Polo JR. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res. 85: 1194-1204 (2007).
24. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.Acta Neuropathol. 120: 287-296 (2010).
25. Grau-Olivares M, Arboix A, Junquè C, Arenaza-Urquijo EM, Rovira M, Bartrès-Faz D. Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment. Cerebrovasc Dis 30: 157-166 (2010).
26. Galante A, Pietroiusti A, Magrini A, Carta S, Franceschelli L, Piccolo P, Pistolese GR, Martelli E, Mastino A, Matteucci C, Grelli S, Favalli C. Leucocyte rheological properties are altered in patients with diffuse atherosclerosis. Thromb Haemost. 77: 1073-1076 (1997)
27. Camandola S, Mattson MP. NF-kappa B as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets. 11: 123-32 (2007).
28. Collister KA, Albensi BC. Potential therapeutic targets in the NFkappaB pathway for Alzheimer's disease. Drug News Perspect. 18: 623-29 (2005).